Centivax

Overview

Centivax is a biotechnology company based in South San Francisco, California, dedicated to developing broad-spectrum vaccines and therapies. Founded during the COVID-19 pandemic, the company utilizes a proprietary computational immune-engineering platform to create vaccines that offer universal protection against various classes of pathogens. Their mission is to protect against a wide range of infectious diseases, including influenza, HIV, COVID-19, and more.

Their lead candidate is a universal influenza vaccine currently in pre-clinical development, with testing conducted in animal models. The pipeline also includes work on universal vaccines for diseases such as HIV, malaria, and tuberculosis, as well as exploratory applications for livestock and military settings. Centivax collaborates with global health organizations and government agencies, such as the Bill & Melinda Gates Foundation and the National Institutes of Health, to address major health challenges and strengthen biodefense initiatives.

Basic Information

Industry	Biotechnology
Founded	2019
Revenue	3M
Headquarters	201 Gateway Boulevard, South San Francisco, CA 94080, United States

Contact Details

Key Focus Areas & Initiatives

COVID-19 therapeutics
Mutating viruses
Epitope-focusing technology
Blood-brain barrier translation technologies
Autoimmune diseases
Viral pathogen targeting
Influenza vaccine
Autoimmune therapeutics
Vaccine clinical trials
Pandemic prevention
Vaccine research
Broad-spectrum vaccines
Medical research
Vaccine development support
Preclinical development
Multidrug-resistant bacteria
Antibody programs
Universal vaccine
Immunology
Pharmaceuticals
B2B services
Research and development in the physical, engineering, and life sciences

Technologies Used

AI
Android
Circle
Gmail
Google Apps
IoT
Micro
Mobile Friendly
Python
Remote
Render
Squarespace ECommerce
Typekit
WordPress.org
YouTube

Centivax | Company Profile